Santa Rally Suppresses The Bears

Novo Nordisk nosedives, Bitcoin ETFs experience outflows, and more from the day.

Presented by

NEWS
Santa Rally Suppresses The Bears

Source: Tenor.com

Stocks bounced back but still closed deeply in the red for the week after the Fed’s rate cut and hawkish outlook. Leading the charge was Nvidia, which is battling a broken trend and trying to regain its momentum. Next week is a light one, with many hoping the light volumes will help the market drift higher for the holidays. 👀

Today's issue covers Novo Nordisk’s worst day in 22 years, Bitcoin ETFs finally experiencing outflows, and other noteworthy pops and drops. 📰

Here’s the S&P 500 heatmap. 11 of 11 sectors closed green, with real estate (+1.82%) leading and consumer discretionary (+0.35%) lagging.

Source: Finviz.com

And here are the closing prices: 

S&P 500

5,930

+1.09%

Nasdaq

19,527

+1.03%

Russell 2000

2,242

+0.94%

Dow Jones

42,840

+1.18%

Most bullish/bearish symbols on Stocktwits at the close: 📈 $MSTR, $PLTR, $MNDY, $RKLB, $APP, 📉 $XPO, $SAIA, $TSLA, $ODFL, $PPC*

*If you’re a business and want to access this data via our API, email us.

COMPANY NEWS
Novo Nordisk Nosedives 😬 

The Danish healthcare giant suffered its largest intraday drop since April 2022, falling 18% after providing an update on its experimental obesity drug, CagriSema. 💉 

The company’s phase 3 trial showed an average weight loss of 22.7% at 68 weeks, falling short of the 25% benchmark the company had hoped for, despite meeting primary endpoints of statistical significance versus placebo.

The news boosted its competitors in the weight loss drug space, including Eli Lilly, Amgen, and Viking Therapeutics. Additionally, it prompted several analyst notes that favored its rivals in the aftermath of these results. 📝 

Still, Stocktwits community sentiment stayed in ‘extremely bullish’ territory, as some users called the selloff “super silly,” citing the drug’s relative effectiveness, overall market size, and Novo’s massive pipeline of drugs. 🛒 

Source: Stocktwits.com

Shares are down 45% off all-time highs, leading investors to hotly debate whether this is a buying opportunity or if the stock’s long-term growth story is broken. 🤷 

SPONSORED
Gift THC edibles for fast-acting fun

Looking for an alcohol alternative to help you enjoy the holidays with family and friends? Cornbread Hemp has you covered with their 10mg THC Edibles. Formulated with a 1:1 ratio of THC to CBD (10mg of each), each gummy provides a balanced feeling of happiness without feeling overwhelmed or couch-locked. Customers have expressed their enjoyment solo or with friends, but either way, they’ll get you through the holidays with a smile on your face.

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

Subscribe to keep reading

This content is free, but you must be subscribed to The Daily Rip to continue reading.

I consent to receive newsletters via email. Sign Up Terms of Service.

Already a subscriber?Sign In.Not now

Reply

or to participate.